Pharmacogenomics market
Pharmacogenomics Market, By Technology (DNA Sequencing, Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, and Others), By Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Pain Management, and Others), By End User (Hospitals & Clinics, Research Institutions and Academic Institutes, Diagnostic Laboratories, and Others) By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
- Apr 2024
- CMI1053
- 156 Pages
- Excel & Pdf
- Biotechnology
Summary
N/A
Table of Content
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
- Market Dynamics
- Global Pharmacogenomics Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
- Global Pharmacogenomics Market, By Technology, 2019 – 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- DNA Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Microarray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Polymerase Chain Reaction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Electrophoresis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Mass Spectrometry
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Overview
- Global Pharmacogenomics Market, By Application, 2019 – 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Cardiovascular Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Neurological Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Overview
- Global Pharmacogenomics Market, By End User, 2019 – 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Research Institutions and Academic Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Overview
- Global Pharmacogenomics Market, By Region, 2019 – 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019–2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pharmigene
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GE HealthCare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Empire Genomics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Oxford Nanopore Technologies plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Myriad Genetics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Macrogen, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BGI Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MapMyGenome
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Invitae Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Profiles
- Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
*Browse 31 market data tables and 26 figures on "Pharmacogenomics Market” - Global forecast to 2031
Segmentation
Detailed Segmentation-
- By Technology:
- DNA Sequencing
- Microarray
- Polymerase Chain Reaction
- Electrophoresis
- Mass Spectrometry
- Others
- By Application:
- Cardiovascular Diseases
- Infectious Diseases
- Oncology
- Neurological Diseases
- Pain Management
- Others
- By End User:
- Hospitals & Clinics
- Research Institutions and Academic Institutes
- Diagnostic Laboratories
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Frequently Asked Questions -
What will be the CAGR of the pharmacogenomics market from 2024 to 2031?
The CAGR of the pharmacogenomics market is projected to be 11.7% from 2024 to 2031.
What are the major factors driving the pharmacogenomics market growth?
Rising demand for precision medicine and increasing inorganic growth strategies are the major factors driving the growth of the pharmacogenomics market.
What are the key factors hampering the growth of the pharmacogenomics market?
Shortage of skilled healthcare professionals and regulatory hurdles and lack of clinical guidelines are the major factors hampering the growth of the pharmacogenomics market.
Which is the leading technology in the pharmacogenomics market?
In terms of technology, DNA sequencing is estimated to dominate the market revenue share in 2024.
Which are the major players operating in the pharmacogenomics market?
Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Pharmigene, Abbott, Agilent Technologies, Inc., QIAGEN, GE HealthCare, Empire Genomics, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies plc., PerkinElmer Inc., Myriad Genetics, Inc., Illumina, Inc., Macrogen, Inc., BGI Genomics, Eurofins Scientific, MapMyGenome, and Invitae Corporation are the major players.
Which region will lead the pharmacogenomics market?
North America is expected to lead the pharmacogenomics market.